DalsnaFinance › IPOs › C4 Therapeutics › IPO
C4 Therapeutics, Inc. completed its initial public offering on NASDAQ on October 2, 2020, pricing at $19.00 a share.
| Ticker | CCCC |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 2, 2020 |
| Offering price | $19.00 |
| Shares offered | 9,600,000 |
| Total raised | $182M |
C4 Therapeutics, Inc. sold 9,600,000 shares at $19.00 each on NASDAQ. Multiplied out, that is $182.4 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $182 million total recorded for the deal.
C4 Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for C4 Therapeutics, Inc.. This page is general information, not investment advice.